{"filing":{"accession_number":"0001935979-26-000077","cik":"0001935979","ticker":"BHVN","company_name":"Biohaven Ltd.","form":"8-K","filing_date":"2026-09-09","report_date":"2026-09-04","primary_document":"bhvn-20260904.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597926000077/bhvn-20260904.htm"},"events":[{"id":32461,"run_id":29825,"accession_number":"0001935979-26-000077","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The filing discloses a partial clinical hold issued by the FDA on September 4, 2026, pausing new patient enrollment in the BHV-7000 program pending additional nonclinical studies of a metabolite with uncertain human safety significance. While the company emphasizes that dosing continues for already-enrolled patients and that BHV7000-303 (a pivotal trial) remains on track for topline data in H2 2026, the regulatory pause on new enrollment represents a material operational setback to the clinical development program. This is a regulatory/operational event that does not fit the specific categories of restatement, auditor change, going concern, material impairment, delisting, bankruptcy, covenant breach, cybersecurity incident, dilutive issuance, material litigation, or debt issuance, making operational_other the most appropriate classification.","company_name":"Biohaven Ltd.","ticker":"BHVN","filing_date":"2026-09-09","form":"8-K","submitted_at":null,"items":[{"id":35635,"accession_number":"0001935979-26-000077","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a partial clinical hold issued by the FDA on September 4, 2026, pausing new patient enrollment in the BHV-7000 program pending additional nonclinical studies of a metabolite with uncertain human safety significance. While the company emphasizes that dosing continues for already-enrolled patients and that BHV7000-303 (a pivotal trial) remains on track for topline data in H2 2026, the regulatory pause on new enrollment represents a material operational setback to the clinical development program. This is a regulatory/operational event that does not fit the specific categories of restatement, auditor change, going concern, material impairment, delisting, bankruptcy, covenant breach, cybersecurity incident, dilutive issuance, material litigation, or debt issuance, making operational_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T10:05:56.144249+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35635,"accession_number":"0001935979-26-000077","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a partial clinical hold issued by the FDA on September 4, 2026, pausing new patient enrollment in the BHV-7000 program pending additional nonclinical studies of a metabolite with uncertain human safety significance. While the company emphasizes that dosing continues for already-enrolled patients and that BHV7000-303 (a pivotal trial) remains on track for topline data in H2 2026, the regulatory pause on new enrollment represents a material operational setback to the clinical development program. This is a regulatory/operational event that does not fit the specific categories of restatement, auditor change, going concern, material impairment, delisting, bankruptcy, covenant breach, cybersecurity incident, dilutive issuance, material litigation, or debt issuance, making operational_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T10:05:56.144249+00:00","company_name":"Biohaven Ltd.","ticker":"BHVN","filing_date":"2026-09-09"}]}